Wealthspire Advisors LLC increased its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 95.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,238 shares of the company's stock after buying an additional 12,339 shares during the period. Wealthspire Advisors LLC's holdings in Colgate-Palmolive were worth $2,365,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in CL. Brighton Jones LLC increased its holdings in Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock valued at $962,000 after buying an additional 450 shares during the last quarter. Bernard Wealth Management Corp. bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $36,000. Grantham Mayo Van Otterloo & Co. LLC raised its stake in Colgate-Palmolive by 4.1% during the fourth quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 12,677 shares of the company's stock worth $1,152,000 after acquiring an additional 495 shares during the period. Cerity Partners LLC lifted its holdings in Colgate-Palmolive by 0.6% in the fourth quarter. Cerity Partners LLC now owns 217,237 shares of the company's stock worth $20,092,000 after acquiring an additional 1,398 shares during the last quarter. Finally, F M Investments LLC boosted its stake in Colgate-Palmolive by 16.5% in the fourth quarter. F M Investments LLC now owns 5,677 shares of the company's stock valued at $516,000 after acquiring an additional 806 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.
Wall Street Analyst Weigh In
Several analysts recently issued reports on CL shares. UBS Group cut their price target on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research note on Monday. Morgan Stanley set a $96.00 price target on shares of Colgate-Palmolive and gave the stock an "overweight" rating in a research report on Monday. Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research report on Monday. Finally, Wall Street Zen lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $98.92.
Get Our Latest Stock Analysis on CL
Colgate-Palmolive Price Performance
Shares of NYSE CL traded down $0.00 during mid-day trading on Friday, reaching $84.71. 4,133,894 shares of the company traded hands, compared to its average volume of 4,850,591. Colgate-Palmolive Company has a fifty-two week low of $82.40 and a fifty-two week high of $109.30. The firm has a market cap of $68.46 billion, a PE ratio of 23.79, a price-to-earnings-growth ratio of 4.41 and a beta of 0.35. The stock has a fifty day simple moving average of $88.76 and a 200-day simple moving average of $90.13. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.28.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.03. The company had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%. The company's quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 EPS. Equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. Colgate-Palmolive's payout ratio is currently 58.43%.
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.